0 XP   0   0   0

Indoco Remedies Limited
Buy, Hold or Sell?

Should you buy, hold or sell Indoco?

I guess you are interested in Indoco Remedies Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Indoco

Let's start. I'm going to help you getting a better view of Indoco Remedies Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Indoco Remedies Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Indoco Remedies Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Indoco Remedies Limited. The closing price on 2023-01-27 was INR338.45 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Indoco Remedies Limited Daily Candlestick Chart
Indoco Remedies Limited Daily Candlestick Chart
Summary









1. Valuation of Indoco




Current price per share

INR338.45

2. Growth of Indoco




Is Indoco growing?

Current yearPrevious yearGrowGrow %
How rich?$111.2m$94.5m$16.6m15.0%

How much money is Indoco making?

Current yearPrevious yearGrowGrow %
Making money$19m$11.4m$7.5m39.9%
Net Profit Margin10.0%7.5%--

How much money comes from the company's main activities?

3. Financial Health of Indoco




Comparing to competitors in the Drugs - Generic industry




  Industry Rankings (Drugs - Generic)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Indoco Remedies Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Indoco earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • A Net Profit Margin of 10.0% means that ₹0.10 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Indoco Remedies Limited:

  • The MRQ is 10.0%. The company is making a huge profit. +2
  • The TTM is 10.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.0%TTM10.0%0.0%
TTM10.0%YOY7.5%+2.6%
TTM10.0%5Y4.7%+5.4%
5Y4.7%10Y6.2%-1.6%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ10.0%9.9%+0.1%
TTM10.0%10.3%-0.3%
YOY7.5%8.0%-0.5%
5Y4.7%6.3%-1.6%
10Y6.2%6.4%-0.2%
1.1.2. Return on Assets

Shows how efficient Indoco is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • 10.4% Return on Assets means that Indoco generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Indoco Remedies Limited:

  • The MRQ is 10.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.4%TTM10.4%0.0%
TTM10.4%YOY7.1%+3.3%
TTM10.4%5Y4.5%+5.9%
5Y4.5%10Y6.2%-1.7%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4%2.7%+7.7%
TTM10.4%2.8%+7.6%
YOY7.1%2.6%+4.5%
5Y4.5%2.0%+2.5%
10Y6.2%2.0%+4.2%
1.1.3. Return on Equity

Shows how efficient Indoco is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • 17.1% Return on Equity means Indoco generated ₹0.17 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Indoco Remedies Limited:

  • The MRQ is 17.1%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.1%TTM17.1%0.0%
TTM17.1%YOY12.1%+5.0%
TTM17.1%5Y7.7%+9.4%
5Y7.7%10Y10.3%-2.7%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ17.1%4.5%+12.6%
TTM17.1%4.7%+12.4%
YOY12.1%5.3%+6.8%
5Y7.7%4.3%+3.4%
10Y10.3%5.0%+5.3%

1.2. Operating Efficiency of Indoco Remedies Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Indoco is operating .

  • Measures how much profit Indoco makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Indoco Remedies Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y6.4%-6.4%
5Y6.4%10Y8.7%-2.3%
1.2.2. Operating Ratio

Measures how efficient Indoco is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • An Operation Ratio of 0.34 means that the operating costs are ₹0.34 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.339. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.339. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.339TTM0.3390.000
TTM0.339YOY0.328+0.011
TTM0.3395Y0.917-0.578
5Y0.91710Y1.075-0.158
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3390.441-0.102
TTM0.3390.490-0.151
YOY0.3280.653-0.325
5Y0.9171.000-0.083
10Y1.0751.083-0.008

1.3. Liquidity of Indoco Remedies Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Indoco is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drugs - Generic industry mean).
  • A Current Ratio of 1.82 means the company has ₹1.82 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Indoco Remedies Limited:

  • The MRQ is 1.821. The company is able to pay all its short-term debts. +1
  • The TTM is 1.821. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.821TTM1.8210.000
TTM1.821YOY1.530+0.291
TTM1.8215Y1.415+0.406
5Y1.41510Y1.450-0.035
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8211.715+0.106
TTM1.8211.635+0.186
YOY1.5301.431+0.099
5Y1.4151.014+0.401
10Y1.4500.886+0.564
1.3.2. Quick Ratio

Measures if Indoco is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • A Quick Ratio of 0.74 means the company can pay off ₹0.74 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.739. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.739. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.739TTM0.7390.000
TTM0.739YOY0.596+0.143
TTM0.7395Y0.577+0.162
5Y0.57710Y0.631-0.054
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7390.860-0.121
TTM0.7390.811-0.072
YOY0.5960.629-0.033
5Y0.5770.498+0.079
10Y0.6310.440+0.191

1.4. Solvency of Indoco Remedies Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Indoco assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Indoco to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that Indoco assets are financed with 39.1% credit (debt) and the remaining percentage (100% - 39.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.391. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.391. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.391TTM0.3910.000
TTM0.391YOY0.415-0.024
TTM0.3915Y0.440-0.049
5Y0.44010Y0.423+0.018
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3910.484-0.093
TTM0.3910.519-0.128
YOY0.4150.513-0.098
5Y0.4400.543-0.103
10Y0.4230.499-0.076
1.4.2. Debt to Equity Ratio

Measures if Indoco is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • A Debt to Equity ratio of 64.3% means that company has ₹0.64 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.643. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.643. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.643TTM0.6430.000
TTM0.643YOY0.710-0.067
TTM0.6435Y0.792-0.150
5Y0.79210Y0.740+0.053
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6430.937-0.294
TTM0.6431.090-0.447
YOY0.7101.056-0.346
5Y0.7921.194-0.402
10Y0.7401.098-0.358

2. Market Valuation of Indoco Remedies Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Indoco generates.

  • Above 15 is considered overpriced but always compare Indoco to the Drugs - Generic industry mean.
  • A PE ratio of 22.42 means the investor is paying ₹22.42 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Indoco Remedies Limited:

  • The EOD is 20.148. Very good. +2
  • The MRQ is 22.416. Very good. +2
  • The TTM is 22.416. Very good. +2
Trends
Current periodCompared to+/- 
EOD20.148MRQ22.416-2.268
MRQ22.416TTM22.4160.000
TTM22.416YOY28.572-6.157
TTM22.4165Y-93.010+115.426
5Y-93.01010Y-37.770-55.240
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD20.14877.207-57.059
MRQ22.41685.784-63.368
TTM22.41692.482-70.066
YOY28.57245.908-17.336
5Y-93.01069.511-162.521
10Y-37.77086.803-124.573
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Indoco.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Indoco Remedies Limited:

  • The MRQ is 13.473. Seems overpriced? -1
  • The TTM is 13.473. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ13.473TTM13.4730.000
TTM13.473YOY7.406+6.067
TTM13.4735Y1,846.760-1,833.287
5Y1,846.76010Y1,165.824+680.936
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ13.473-7.855+21.328
TTM13.4730.877+12.596
YOY7.4060.085+7.321
5Y1,846.760-0.157+1,846.917
10Y1,165.8240.358+1,165.466

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Indoco is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • A PB ratio of 3.84 means the investor is paying ₹3.84 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Indoco Remedies Limited:

  • The EOD is 3.448. Neutral. Compare to industry.
  • The MRQ is 3.836. Neutral. Compare to industry.
  • The TTM is 3.836. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.448MRQ3.836-0.388
MRQ3.836TTM3.8360.000
TTM3.836YOY3.457+0.379
TTM3.8365Y3.167+0.668
5Y3.16710Y3.697-0.529
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD3.4483.452-0.004
MRQ3.8363.8360.000
TTM3.8364.390-0.554
YOY3.4573.369+0.088
5Y3.1673.239-0.072
10Y3.6972.355+1.342
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Indoco Remedies Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.72014.7200%9.704+52%5.498+168%10.908+35%
Book Value Growth--1.1761.1760%1.132+4%1.070+10%1.091+8%
Book Value Per Share--98.17098.1700%83.450+18%80.061+23%71.054+38%
Book Value Per Share Growth--1.1761.1760%1.132+4%1.070+10%1.091+8%
Current Ratio--1.8211.8210%1.530+19%1.415+29%1.450+26%
Debt To Asset Ratio--0.3910.3910%0.415-6%0.440-11%0.423-7%
Debt To Equity Ratio--0.6430.6430%0.710-9%0.792-19%0.740-13%
Dividend Per Share--1.4971.4970%0.303+395%1.058+41%1.340+12%
Dividend Per Share Growth--4.9464.9460%0.829+497%2.807+76%2.196+125%
Eps--16.79916.7990%10.097+66%6.733+150%7.355+128%
Eps Growth--1.6641.6640%3.858-57%3.258-49%2.456-32%
Free Cash Flow Per Share--5.2645.2640%0.583+803%2.967+77%1.539+242%
Free Cash Flow Per Share Growth--9.0279.0270%0.083+10717%3.376+167%1.375+556%
Free Cash Flow To Equity Per Share--0.4490.4490%-2.659+693%-1.224+373%-0.174+139%
Free Cash Flow To Equity Per Share Growth--2.1692.1690%-56.465+2704%-10.748+596%-1.857+186%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--145.254--------
Intrinsic Value_10Y_min--121.466--------
Intrinsic Value_1Y_max--7.283--------
Intrinsic Value_1Y_min--7.077--------
Intrinsic Value_3Y_max--27.426--------
Intrinsic Value_3Y_min--25.803--------
Intrinsic Value_5Y_max--54.250--------
Intrinsic Value_5Y_min--49.358--------
Net Profit Margin--0.1000.1000%0.075+34%0.047+115%0.062+61%
Operating Margin----0%-0%0.064-100%0.087-100%
Operating Ratio--0.3390.3390%0.328+3%0.917-63%1.075-68%
Pb Ratio3.448-11%3.8363.8360%3.457+11%3.167+21%3.697+4%
Pe Ratio20.148-11%22.41622.4160%28.572-22%-93.010+515%-37.770+268%
Peg Ratio--13.47313.4730%7.406+82%1846.760-99%1165.824-99%
Price Per Share338.450-11%376.550376.5500%288.500+31%257.570+46%258.894+45%
Price To Total Gains Ratio20.870-11%23.21923.2190%28.831-19%-77.327+433%-31.227+234%
Profit Growth--1.6641.6640%3.858-57%3.258-49%2.456-32%
Quick Ratio--0.7390.7390%0.596+24%0.577+28%0.631+17%
Return On Assets--0.1040.1040%0.071+47%0.045+132%0.062+69%
Return On Equity--0.1710.1710%0.121+41%0.077+123%0.103+65%
Revenue Growth--1.2411.2410%1.122+11%1.077+15%1.102+13%
Total Gains Per Share--16.21716.2170%10.006+62%6.556+147%12.248+32%
Total Gains Per Share Growth--1.6211.6210%4.133-61%3.009-46%2.156-25%
Usd Book Value--111270732.300111270732.3000%94585843.800+18%90744568.560+23%80535700.033+38%
Usd Book Value Change Per Share--0.1810.1810%0.119+52%0.068+168%0.134+35%
Usd Book Value Per Share--1.2071.2070%1.026+18%0.985+23%0.874+38%
Usd Dividend Per Share--0.0180.0180%0.004+395%0.013+41%0.016+12%
Usd Eps--0.2070.2070%0.124+66%0.083+150%0.090+128%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.0650.0650%0.007+803%0.036+77%0.019+242%
Usd Free Cash Flow To Equity Per Share--0.0060.0060%-0.033+693%-0.015+373%-0.002+139%
Usd Price Per Share4.163-11%4.6324.6320%3.549+31%3.168+46%3.184+45%
Usd Profit--19040338.50019040338.5000%11444596.500+66%7631397.240+150%8336858.000+128%
Usd Revenue--189512680.500189512680.5000%152707907.100+24%145204174.020+31%131174048.367+44%
Usd Total Gains Per Share--0.1990.1990%0.123+62%0.081+147%0.151+32%
 EOD+3 -2MRQTTM+0 -0YOY+32 -85Y+34 -710Y+34 -7

3.2. Fundamental Score

Let's check the fundamental score of Indoco Remedies Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.148
Price to Book Ratio (EOD)Between0-13.448
Net Profit Margin (MRQ)Greater than00.100
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.739
Current Ratio (MRQ)Greater than11.821
Debt to Asset Ratio (MRQ)Less than10.391
Debt to Equity Ratio (MRQ)Less than10.643
Return on Equity (MRQ)Greater than0.150.171
Return on Assets (MRQ)Greater than0.050.104
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Indoco Remedies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose348.500
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets14,860,921
Total Liabilities5,814,520
Total Stockholder Equity9,046,401
 As reported
Total Liabilities 5,814,520
Total Stockholder Equity+ 9,046,401
Total Assets = 14,860,921

Assets

Total Assets14,860,921
Total Current Assets7,736,191
Long-term Assets7,736,191
Total Current Assets
Cash And Cash Equivalents 167,728
Net Receivables 2,972,446
Inventory 3,222,816
Other Current Assets 1,021,891
Total Current Assets  (as reported)7,736,191
Total Current Assets  (calculated)7,384,881
+/- 351,310
Long-term Assets
Property Plant Equipment 5,846,626
Goodwill 900
Intangible Assets 918,781
Long-term Assets  (as reported)0
Long-term Assets  (calculated)6,766,307
+/- 6,766,307

Liabilities & Shareholders' Equity

Total Current Liabilities4,248,536
Long-term Liabilities-
Total Stockholder Equity9,046,401
Total Current Liabilities
Short-term Debt 1,037,330
Total Current Liabilities  (as reported)4,248,536
Total Current Liabilities  (calculated)1,037,330
+/- 3,211,206
Long-term Liabilities
Long term Debt Total 1,068,472
Capital Lease Obligations Min Short Term Debt-1,037,330
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)31,142
+/- 31,142
Total Stockholder Equity
Common Stock184,301
Retained Earnings 8,220,007
Capital Surplus 642,093
Total Stockholder Equity (as reported)9,046,401
Total Stockholder Equity (calculated)9,046,401
+/-0
Other
Cash and Short Term Investments 167,728
Common Stock Shares Outstanding 92,150
Liabilities and Stockholders Equity 14,860,921



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
7,294,139
8,455,733
9,405,807
11,967,479
12,379,289
12,580,498
12,715,951
13,150,615
14,860,921
14,860,92113,150,61512,715,95112,580,49812,379,28911,967,4799,405,8078,455,7337,294,139
   > Total Current Assets 
3,045,600
3,853,564
4,645,510
5,720,503
5,389,612
5,380,522
5,631,038
6,225,262
7,736,191
7,736,1916,225,2625,631,0385,380,5225,389,6125,720,5034,645,5103,853,5643,045,600
       Cash And Cash Equivalents 
133,855
153,985
126,335
625,860
80,032
202,730
379,300
87,868
167,728
167,72887,868379,300202,73080,032625,860126,335153,985133,855
       Short-term Investments 
0
0
156,798
129,119
17,486
99,770
29,974
10
0
01029,97499,77017,486129,119156,79800
       Net Receivables 
1,383,970
1,557,055
1,888,339
2,156,777
2,095,059
1,958,372
2,101,439
2,338,238
2,972,446
2,972,4462,338,2382,101,4391,958,3722,095,0592,156,7771,888,3391,557,0551,383,970
       Inventory 
1,102,179
1,491,213
1,736,737
1,956,245
2,020,062
1,936,564
2,197,455
2,585,014
3,222,816
3,222,8162,585,0142,197,4551,936,5642,020,0621,956,2451,736,7371,491,2131,102,179
       Other Current Assets 
387,624
612,143
102,231
816,264
1,118,290
1,121,694
992,317
1,085,207
1,021,891
1,021,8911,085,207992,3171,121,6941,118,290816,264102,231612,143387,624
   > Long-term Assets 
0
0
0
6,244,848
6,989,677
7,199,976
7,084,913
0
0
007,084,9137,199,9766,989,6776,244,848000
       Property Plant Equipment 
3,204,886
3,210,298
3,401,867
4,331,315
5,168,866
5,578,466
5,489,455
5,535,308
5,846,626
5,846,6265,535,3085,489,4555,578,4665,168,8664,331,3153,401,8673,210,2983,204,886
       Goodwill 
1,192
3,052
3,052
900
900
900
900
900
900
9009009009009009003,0523,0521,192
       Long Term Investments 
1,700
1,700
210
210
0
0
0
0
0
000002102101,7001,700
       Intangible Assets 
489,426
811,830
879,417
973,015
1,074,420
951,425
914,093
845,121
918,781
918,781845,121914,093951,4251,074,420973,015879,417811,830489,426
       Long-term Assets Other 
0
0
0
436,910
0
0
-15
0
0
00-1500436,910000
> Total Liabilities 
2,720,152
3,267,736
3,640,630
5,454,115
5,629,478
5,974,274
5,920,257
5,460,709
5,814,520
5,814,5205,460,7095,920,2575,974,2745,629,4785,454,1153,640,6303,267,7362,720,152
   > Total Current Liabilities 
2,021,463
2,621,217
3,029,519
3,903,870
4,173,612
4,455,012
4,589,864
4,069,199
4,248,536
4,248,5364,069,1994,589,8644,455,0124,173,6123,903,8703,029,5192,621,2172,021,463
       Short-term Debt 
919,941
965,431
872,316
1,183,580
1,099,314
1,133,937
1,059,786
1,163,238
1,037,330
1,037,3301,163,2381,059,7861,133,9371,099,3141,183,580872,316965,431919,941
       Short Long Term Debt 
919,941
965,431
1,398,233
2,795,369
1,591,478
1,688,376
1,658,752
0
0
001,658,7521,688,3761,591,4782,795,3691,398,233965,431919,941
       Accounts payable 
706,611
1,198,556
1,313,111
1,640,293
1,495,497
1,707,227
1,656,037
0
0
001,656,0371,707,2271,495,4971,640,2931,313,1111,198,556706,611
       Other Current Liabilities 
466,291
517,840
527,793
579,347
753,452
798,386
986,431
0
0
00986,431798,386753,452579,347527,793517,840466,291
   > Long-term Liabilities 
0
0
0
1,616,074
1,455,858
1,519,262
1,330,393
0
0
001,330,3931,519,2621,455,8581,616,074000
       Long term Debt Total 
0
0
378,853
1,323,097
1,232,759
1,286,571
1,024,211
1,039,444
1,068,472
1,068,4721,039,4441,024,2111,286,5711,232,7591,323,097378,85300
       Capital Lease Obligations 
0
0
0
0
0
0
60,085
0
0
0060,085000000
       Long-term Liabilities Other 
0
0
0
44,467
0
-1
1
0
0
001-1044,467000
> Total Stockholder Equity
4,571,507
5,187,997
5,765,177
6,513,364
6,749,811
6,606,224
6,795,694
7,689,906
9,046,401
9,046,4017,689,9066,795,6946,606,2246,749,8116,513,3645,765,1775,187,9974,571,507
   Common Stock
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301184,301184,301184,301184,301184,301184,301184,301184,301
   Retained Earnings 
3,751,587
4,356,642
4,937,314
5,687,010
5,923,451
5,779,830
5,969,300
6,863,512
8,220,007
8,220,0076,863,5125,969,3005,779,8305,923,4515,687,0104,937,3144,356,6423,751,587
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 
0
0
644,195
642,093
642,093
642,093
642,093
642,093
642,093
642,093642,093642,093642,093642,093642,093644,19500
   Treasury Stock000000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue15,407,535
Cost of Revenue-5,223,793
Gross Profit10,183,74210,183,742
 
Operating Income (+$)
Gross Profit10,183,742
Operating Expense--
Operating Income2,489,16110,183,742
 
Operating Expense (+$)
Research Development-
Selling General Administrative5,823,573
Selling And Marketing Expenses-
Operating Expense-5,823,573
 
Net Interest Income (+$)
Interest Income126,916
Interest Expense--
Net Interest Income-126,916
 
Pretax Income (+$)
Operating Income2,489,161
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,365,7122,489,161
EBIT - interestExpense = 0
1,547,995
1,547,995
Interest Expense-
Earnings Before Interest and Taxes (ebit)-2,365,712
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax2,365,712
Tax Provision-817,717
Net Income From Continuing Ops-1,547,995
Net Income1,547,995
Net Income Applicable To Common Shares1,547,995
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CUBE1.CC
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CUBE1.CC.

CUBE1.CC Daily Candlestick Chart
CTSI.CC
15 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CTSI.CC.

CTSI.CC Daily Candlestick Chart
CTI.CC
15 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CTI.CC.

CTI.CC Daily Candlestick Chart
CRV1.CC
17 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRV1.CC.

CRV1.CC Daily Candlestick Chart
CRU.CC
17 minutes ago

I found you a Golden Cross on the daily chart of CRU.CC.

CRU.CC Daily Candlestick Chart
CRPT.CC
17 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRPT.CC.

CRPT.CC Daily Candlestick Chart
CREP.CC
17 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CREP.CC.

CREP.CC Daily Candlestick Chart
CORN.CC
19 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CORN.CC.

CORN.CC Daily Candlestick Chart
CORAL.CC
19 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of CORAL.CC.

CORAL.CC Daily Candlestick Chart
CONTENTBOX.CC
19 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CONTENTBOX.CC.

CONTENTBOX.CC Daily Candlestick Chart
CLV.CC
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CLV.CC.

CLV.CC Daily Candlestick Chart
CIV.CC
22 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of CIV.CC.

CIV.CC Daily Candlestick Chart
NGU24-NYM.COMM
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
7 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
7 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart